Manufacturer of Controlled Substances; Notice of Registration, 35152-35153 [E8-13911]

Download as PDF 35152 Federal Register / Vol. 73, No. 120 / Friday, June 20, 2008 / Notices www.usdoj.gov/enrd/ Consent_Decrees.html. A copy of the Magellan Consent Decree also may be obtained by mail from the Consent Decree Library, P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611 or by faxing or e-mailing a request to Tonia Fleetwood (tonia.fleetwood@usdoj.gov), fax no. (202) 514–0097, phone confirmation number (202) 514–1547. In requesting a copy from the Consent Decree Library, please enclose a check in the amount of $49.75 (25 cents per page reproduction cost) payable to the U.S. Treasury. Maureen M. Katz, Assistant Section Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. E8–13935 Filed 6–19–08; 8:45 am] BILLING CODE 4410–15–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated April 17, 2006 and published in the Federal Register on April 21, 2006, (71 FR 20729), and as corrected by Notice dated May 15, 2006, and published in the Federal Register on May 22, 2006, (71 FR 29354), Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816, made application to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances in schedule II: Drug Schedule jlentini on PROD1PC65 with NOTICES Raw Opium (9600) ....................... Concentrate of Poppy Straw (9670). II II The company plans to import the basic classes of controlled substances to manufacture bulk active pharmaceutical ingredients. The company is registered with DEA as a manufacturer of several controlled substances that are manufactured from raw opium and concentrate of poppy straw. Comments, objections, and requests for a hearing were received. However, after a thorough review of this matter DEA has concluded that, per 21 CFR 1301.34(a), the objectors are not entitled to a hearing. As explained in the Correction to Notice of Application dated January 18, 2007, pertaining to Rhodes Technologies et al., (72 FR 3417, January 25, 2007), comments and requests for hearings on applications to import narcotic raw material are not appropriate. VerDate Aug<31>2005 16:53 Jun 19, 2008 Jkt 214001 DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Rhodes Technologies to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA investigated Rhodes Technologies to ensure that the company’s registration would be consistent with the public interest. The investigation included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. After investigating these and other matters, I have concluded that registering Rhodes Technologies to import raw opium and concentrate of poppy straw is consistent with the factors set forth in 21 U.S.C. 823(a)(2)– (6), as incorporated in 21 U.S.C. 958(a). The DEA also considered whether the registration of Rhodes Technologies would be consistent with 21 U.S.C. 823(a)(1) that requires the DEA to limit the importation of certain controlled substances (including raw opium and concentrate of poppy straw) ‘‘to a number of establishments which can produce an adequate and uninterrupted supply of these substances under adequately competitive conditions * * *.’’ I find that the establishments currently registered with DEA to import raw opium and concentrate of poppy straw provide an adequate and uninterrupted supply of those substances. The DEA found no evidence that the supply of such substances was inadequate or interrupted in supplying the needs of the United States for legitimate medical, scientific, research, and industrial purposes. However, I find that the adequate and uninterrupted supply of these substances did not occur under adequately competitive conditions. Specifically, I find that Rhodes Technologies has demonstrated that the current importers of raw opium and concentrate of poppy straw have, in some cases, refused to sell these substances to Rhodes Technologies. Some of the current importers also use their position to demand restrictive contractual terms when selling narcotic raw material to Rhodes Technologies. Many of the current importers also manufacture active pharmaceutical ingredients or have corporate ties to firms that manufacture active pharmaceutical ingredients from raw opium and concentrate of poppy straw. These importers have a direct financial interest in refusing to sell narcotic raw PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 material to Rhodes Technologies or in demanding significant contractual restrictions when selling narcotic raw material to Rhodes Technologies. Based on the information in the investigative file that is summarized herein, I find that the current importation of raw opium and concentrate of poppy straw is not being conducted under adequately competitive conditions. Therefore, under 21 U.S.C. 823(a)(1), DEA may grant the application of Rhodes Technologies to import raw opium and concentrate of poppy straw. Having already found that registering Rhodes Technologies to import raw opium and concentrate of poppy straw is consistent with the factors set forth in 21 U.S.C. 823(a)(2)–(6), I find that the statutory factor set forth in 21 U.S.C. 823(a)(1) also weighs in favor of granting the application. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: June 16, 2008. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E8–13912 Filed 6–19–08; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated February 20, 2008 and published in the Federal Register on February 29, 2008, (73 FR 11149), Stepan Company, Natural Products Dept., 100 W. Hunter Avenue, Maywood, New Jersey 07607, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II: Drug Cocaine (9041) ............................. Benzoylecgonine (9180) ............... Schedule II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Coca Leaves (9040) has been removed as a bulk manufacturing drug code for the company. No comments or objections have been received. DEA has considered the E:\FR\FM\20JNN1.SGM 20JNN1 Federal Register / Vol. 73, No. 120 / Friday, June 20, 2008 / Notices factors in 21 U.S.C. 823(a) and determined that the registration of Stepan Company to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Stepan Company to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: June 13, 2008. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E8–13911 Filed 6–19–08; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR Office of the Secretary Submission for OMB Review: Comment Request jlentini on PROD1PC65 with NOTICES June 16, 2008. The Department of Labor (DOL) hereby announces the submission of the following public information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (Pub. L. 104–13, 44 U.S.C. chapter 35). A copy of this ICR, with applicable supporting documentation; including among other things a description of the likely respondents, proposed frequency of response, and estimated total burden may be obtained from the RegInfo.gov Web site at https://www.reginfo.gov/ public/do/PRAMain or by contacting Darrin King on 202–693–4129 (this is not a toll-free number)/e-mail: king.darrin@dol.gov. Interested parties are encouraged to send comments to the Office of Information and Regulatory Affairs, Attn: OMB Desk Officer for the Veterans’ Employment and Training Service (VETS), Office of Management and Budget, Room 10235, Washington, DC 20503, Telephone: 202–395–7316 / Fax: 202–395–6974 (these are not tollfree numbers), e-mail: OIRA_submission@omb.eop.gov within 30 days from the date of this publication VerDate Aug<31>2005 16:53 Jun 19, 2008 Jkt 214001 in the Federal Register. In order to ensure the appropriate consideration, comments should reference the OMB Control Number (see below). The OMB is particularly interested in comments which: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Agency: Veterans’ Employment and Training Service. Type of Review: New Collection (Request for a new OMB Control Number). Title of Collection: Veteran Employment Outcomes Study. OMB Control Number: 1293–0NEW. Affected Public: Individuals or Households. Estimated Number of Respondents: 1,068. Estimated Total Annual Burden Hours: 267. Estimated Total Annual Costs Burden: $0. Description: The purpose of this study is to learn more about veteran users of One-Stop Career Centers who do not appear to have had successful employment outcomes. The survey data collected will help determine to what extent the apparent lack of successful outcomes for veteran job seekers, as measured by the participating states. Further, this collection will allow DOL to learn key characteristics and reasons why some veterans have difficulty or fail to find jobs, learn what services were received and what veterans thought of them, and learn what services were not received and whether they were needed. For additional information, see related notice published at 73 FR 11956 on March 5, 2008. Darrin A. King, Acting Departmental Clearance Officer. [FR Doc. E8–13981 Filed 6–19–08; 8:45 am] BILLING CODE 4510–79–P PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 35153 DEPARTMENT OF LABOR Employment and Training Administration [TA–W–61,698; TA–W–61,698B] Dan River, Inc., 1325 Avenue of the Americas, New York, New York; Including Employees in Support of Dan River, Inc., 1325 Avenue of the Americas, New York, New York Operating at Various Locations in the State of New Jersey; Amended Certification Regarding Eligibility To Apply for Worker Adjustment Assistance and Alternative Trade Adjustment Assistance In accordance with Section 223 of the Trade Act of 1974 (19 U.S.C. 2273), and Section 246 of the Trade Act of 1974 (26 U.S.C. 2813), as amended, the Department of Labor issued a Certification Regarding Eligibility to Apply for Worker Adjustment Assistance and Alternative Trade Adjustment Assistance on July 13, 2007, applicable to workers of Dan River, Inc., 1325 Avenue of The Americas, New York, New York. The notice was published in the Federal Register on June 3, 2008 (73 FR 31716). The certification was amended on May 27, 2008 to include an employee of the subject firm operating out of Randolph, New Jersey. The notice was published in the Federal Register on June 3, 2008 (73 FR 31713). At the request of the State agency, the Department reviewed the certification for workers of the subject firm. New information shows that worker separations have occurred involving employees in support of and under the control of the New York, New York facility of Dan River, Inc., 1325 Avenue of The Americas, New York, New York operating out of various locations in the state of New Jersey. Based on these findings, the Department is amending this certification to include employee in support of 1325 Avenue of The Americas, New York, New York facility operating out of various locations in state of New Jersey. The intent of the Department’s certification is to include all workers of Dan River, Inc., 1325 Avenue of The Americas, New York, New York who were adversely affected by a shift in production to Mexico. The amended notice applicable to TA–W–61,698 is hereby issued as follows: All workers of Dan River, Inc., 1325 Avenue of The Americas, New York, New York (TA– W–61,698), including employees in support of Dan River, Inc., 1325 Avenue of The E:\FR\FM\20JNN1.SGM 20JNN1

Agencies

[Federal Register Volume 73, Number 120 (Friday, June 20, 2008)]
[Notices]
[Pages 35152-35153]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-13911]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated February 20, 2008 and published in the Federal 
Register on February 29, 2008, (73 FR 11149), Stepan Company, Natural 
Products Dept., 100 W. Hunter Avenue, Maywood, New Jersey 07607, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed in schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cocaine (9041).............................  II
Benzoylecgonine (9180).....................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    Coca Leaves (9040) has been removed as a bulk manufacturing drug 
code for the company.
    No comments or objections have been received. DEA has considered 
the

[[Page 35153]]

factors in 21 U.S.C. 823(a) and determined that the registration of 
Stepan Company to manufacture the listed basic classes of controlled 
substances is consistent with the public interest at this time. DEA has 
investigated Stepan Company to ensure that the company's registration 
is consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above 
named company is granted registration as a bulk manufacturer of the 
basic classes of controlled substances listed.

    Dated: June 13, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E8-13911 Filed 6-19-08; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.